Anticoagulants in pregnancy: a review of indications and complications.
D000014:Abnormalities, Drug-Induced; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors; D003374:Coumarins / Q000009:adverse effects; D004617:Embolism / Q000517:prevention & control; D005260:Female; D005333:Fetus; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D006473:Postpartum Hemorrhage / Q000139:chemically induced; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000188:drug therapy; D014599:Uterus; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000627:therapeutic use
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D003374:Coumarins; D014812:Vitamin K; D006493:Heparin